Call to strengthen academia-industry partnership in pharma sector
The role of academia in strengthening the Indian pharma industry and boosting research was debated at Synergy 2018, a NIPER-pharma industry workshop held recently in Hyderabad.
Ms. Shashi Bala Singh, Director of National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, said the institute was trying to drive basic research and translational research by bringing together academia and industry on the same platform.
Speaking at the event, Mr. G. N. Singh, Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission, said that big innovations come from simple ideas and not just infrastructure facilities.
Industry representatives felt that technology reproducibility was important in the Indian context. Multi-disci-plinary research and studies should be encouraged and sustenance of such research can be enhanced by having industrial collaborations.
Panellists at the event also felt that the industry could change tremendously in the coming decade with a strong influence of regulatory aspect on its growth. Similarly, speakers felt that investment-oriented thinking of industries and basic research-oriented thinking of academics should resonate in the same frequency in order to bridge the gap and strengthen collaborations.
Looking for chemical products? Let suppliers reach out to you!
2026-06-24
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Approves Datopotamab Deruxtecan for Second Indication 45 Percent Response Rate in EGFR Mutant Lung Cancer
-
UK Parliament Approves Assisted Dying Bill 7500 Could Seek Euthanasia Annually
-
4 Pharma Firms Lose Licenses in Jammu and Kashmir Amid Illegal Drug Sales Crackdown
-
Over 100 Foreign Pharma Executives Join Chinese Firms in 5 Years Industry Faces Key Challenges
-
Merck’s New CMV Drug Approved in China Targets Nearly 40000 HSCT Patients
-
Trump Warns of 200 Percent Tariffs on Pharma Companies by August 1 India Trade Deal Among Top Priorities
-
Emcure Seals Exclusive Deal for Sanofi’s Oral Diabetes Brands Millions of Indian Patients to Benefit
-
AstraZeneca Rare Disease Drug Misses Phase 3 Target Hope Shifts to Subgroup Data
-
Over 22,000 New Cases in India AstraZeneca Gets CDSCO Green Light for Muscle-Invasive Bladder Cancer Drug
-
60 Percent Workforce Held by Top 10 Firms! China’s TCM Industry Faces Fierce Reshuffle as Private Leaders Expand Fast
Recommend Reading
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
Novo Nordisk Submits Higher Dose of Wegovy One in Three Achieves Over 25 Percent Weight Loss
-
Eurofragance Opens New Creative Center in Jakarta to Expand Its Asian Footprint
-
Acetic Acid Market Trends Consolidate (May 18–May 24)
-
Merck Establishes New Semiconductor Hub in Taiwan
-
Formic Acid Upward Cycle Ends as Scheduled
-
Formic Acid Prices First Rise and Then Stabilize